ITRF - The Laser-hybrid Accelerator for Radiobiological Applications (LhARA) - preliminary activity - WP4, Ionacoustic Dose Mapping

[https://ccap.hep.ph.ic.ac.uk/trac/raw-attachment/wiki/Communication/Notes/CCAP-TN-10.pdf].中介绍了拉拉合作关于最初五年研发计划的建议，该计划旨在提供基本的降低风险的研发计划，并建立拉拉设施的技术设计该提案与UKRI基础设施基金关于建立离子治疗研究基金(ITRF)的提案中确定的时间表保持一致。拉拉是这项创新及科技基金建议的基础，该建议是为支持一项为期两年的“初步活动”提供资源。为期两年的初步活动的主要成果是该设施的完整概念设计报告。这一工作包WP4是这项工作的初步离子-声波剂量图组成部分。

The LhARA collaboration's proposal for an initial five-year R&D programme designed to deliver the essential risk-mitigating R&D programme and to establish the technical design for the LhARA facility is presented in [https://ccap.hep.ph.ic.ac.uk/trac/raw-attachment/wiki/Communication/Notes/CCAP-TN-10.pdf]. The proposal was aligned to the timescale defined in the proposal to the UKRI Infrastructure Fund for the establishment of the Ion Therapy Research Facility (ITRF). LhARA formed the basis for this ITRF proposal, which is for resources to support a two-year "Preliminary Activity". The principal deliverable of the two-year Preliminary Activity is a complete Conceptual Design Report for the facility. This work package, WP4, is the preliminary ion-acoustic dose mapping component of the work.